title: Growth effects of raloxifene, estradiol, medroxy-progesterone acetate, and progesterone on human endometrial adenocarcinoma cells.
authors.forename: Robert
authors.initials: R
authors.lastname: Boostanfar
authors.forename: Charles A
authors.initials: CA
authors.lastname: Amezcua
authors.forename: David E
authors.initials: DE
authors.lastname: Tourgeman
authors.forename: Subir
authors.initials: S
authors.lastname: Roy
authors.forename: Juan C
authors.initials: JC
authors.lastname: Felix
authors.forename: Frank Z
authors.initials: FZ
authors.lastname: Stanczyk
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology*; D002455:Cell Division / Q000187:drug effects; D016889:Endometrial Neoplasms / Q000473:pathology*; D004958:Estradiol / Q000494:pharmacology; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000494:pharmacology; D011374:Progesterone / Q000494:pharmacology; D020849:Raloxifene Hydrochloride / Q000494:pharmacology*; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D014407:Tumor Cells, Cultured
chemical_list: D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D011374:Progesterone; D004958:Estradiol; D017258:Medroxyprogesterone Acetate